๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Venture Capital Exit Rights

โœ Scribed by Carsten Bienz; Uwe Walz


Book ID
109125488
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
240 KB
Volume
19
Category
Article
ISSN
1058-6407

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Innovation and Venture Capital Exits
โœ Armin Schwienbacher ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 327 KB
Legality and venture capital exits
โœ Douglas Cumming; Grant Fleming; Armin Schwienbacher ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 334 KB
Innovation and venture capital exit perf
โœ Pierre Nadeau ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 410 KB

## Abstract Technological innovation is an important strategic resource of the entrepreneurial firm that can attract venture capital investment, provide competitive advantage and produce superior performance.

Preplanned exit strategies in venture ca
โœ Cumming, Douglas (author);Johan, Sofia Atiqah binti (author) ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 339 KB
Preplanned exit strategies in venture ca
โœ Cumming, Douglas (author);Johan, Sofia Atiqah binti (author) ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 339 KB
VC rising, but exits uncertain: Venture
โœ Mark Telford ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 57 KB

Nanomaterials supplier Oxonica plc, which was spun-out from the UK's University of Oxford in 1999, has acquired Nanoplex Technologies, which was founded in 2002 in Mountain View, California, for ~17% of the equity of the enlarged group. Nanoplex develops diagnostic products based on metal nanopartic